193 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
SNY vs. NVO: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/764067/sny-vs-nvo-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-764067 Feb 13, 2020 - SNY vs. NVO: Which Stock Is the Better Value Option?
Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split http://www.zacks.com/stock/news/754444/pharma-stock-roundup-bmy-gsk-sny-q4-results-mrk-earnings-split?cid=CS-ZC-FT-analyst_blog|stock_roundup-754444 Feb 07, 2020 - Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results.
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jørgensen on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4321616-novo-nordisk-s-nvo-ceo-lars-fruergaard-jorgensen-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Feb 05, 2020 - Novo Nordisk A/S (NYSE:NVO) Q4 2019 Earnings Conference Call February 05, 2020, 07:00 AM ET Company Participants Lars Fruergaard Jørgensen - CEO Mads Krogsgaard Thomsen - Chief Science Officer Karsten
Novo Nordisk (NVO) Q4 Earnings Match Estimates, Revenues Beat http://www.zacks.com/stock/news/750701/novo-nordisk-nvo-q4-earnings-match-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-750701 Feb 05, 2020 - Novo Nordisk (NVO) posts in-line earnings, while revenues beat estimates in the fourth quarter of 2019.
SNY vs. NVO: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/736878/sny-vs-nvo-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-736878 Jan 28, 2020 - SNY vs. NVO: Which Stock Is the Better Value Option?
Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction http://www.zacks.com/stock/news/722212/novo-nordisks-ozempic-gets-fda-nod-for-cv-risk-reduction?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-722212 Jan 17, 2020 - Novo Nordisk's (NVO) Ozempic gets FDA approval for reducing the risk of major adverse cardiovascular events in people with type II diabetes and established CVD.
Top Research Reports for Microsoft, Wells Fargo & Chevron http://www.zacks.com/research-daily/673244/top-research-reports-for-microsoft-wells-fargo-chevron?cid=CS-ZC-FT-research_daily-673244 Dec 16, 2019 - Top Research Reports for Microsoft, Wells Fargo & Chevron
With A Rebrand And A New App, Will WW International Rebound In 2020? https://www.fool.com/investing/2019/11/21/with-a-rebrand-and-a-new-app-will-ww-international.aspx?source=iedfolrf0000001 Nov 21, 2019 - Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer third-quarter revenue results?
NVO: Barclays ups to Overweight https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191118091502 Nov 18, 2019 - Barclays issues rating change for NVO
Here's Why AstraZeneca's (AZN) Shares Are Up Year to Date http://www.zacks.com/stock/news/625339/heres-why-astrazenecas-azn-shares-are-up-year-to-date?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-625339 Nov 18, 2019 - AstraZeneca's (AZN) stock is on an upward trajectory this year. Let us take a look at the reasons for the same.

Pages: 123456...20

Page 1>